• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类泛素化SUMO系统对p53家族成员的调控

Regulation of p53 family members by the ubiquitin-like SUMO system.

作者信息

Stehmeier Per, Muller Stefan

机构信息

Department of Molecular Cell Biology, Max Planck Institute of Biochemistry, Am Klopferspitz 18, D-82152 Martinsried, Germany.

出版信息

DNA Repair (Amst). 2009 Apr 5;8(4):491-8. doi: 10.1016/j.dnarep.2009.01.002. Epub 2009 Feb 12.

DOI:10.1016/j.dnarep.2009.01.002
PMID:19213614
Abstract

p53 and its cousins p63 and p73 are critical regulators of the genotoxic stress response in mammalian cells. Their activity is controlled by an intricate network of post-translational modifications. The ubiquitin-like SUMO system targets all three family members and modulates their transcriptional activity, stability or subcellular trafficking. While the SUMO system appears to primarily exert a negative regulatory function on p73 and p63, both activating and repressing activities have been reported on p53. Here we will give a synopsis of the multifaceted effects of SUMO on p53 family members.

摘要

p53及其同源蛋白p63和p73是哺乳动物细胞基因毒性应激反应的关键调节因子。它们的活性由一个复杂的翻译后修饰网络控制。类泛素化小泛素样修饰物(SUMO)系统作用于所有这三个家族成员,并调节它们的转录活性、稳定性或亚细胞运输。虽然SUMO系统似乎主要对p73和p63发挥负调节功能,但关于p53既有激活活性也有抑制活性的报道。在此,我们将概述SUMO对p53家族成员的多方面影响。

相似文献

1
Regulation of p53 family members by the ubiquitin-like SUMO system.类泛素化SUMO系统对p53家族成员的调控
DNA Repair (Amst). 2009 Apr 5;8(4):491-8. doi: 10.1016/j.dnarep.2009.01.002. Epub 2009 Feb 12.
2
p73 and p63 protein stability: the way to regulate function?p73与p63蛋白稳定性:调节功能的方式?
Biochem Pharmacol. 2003 Oct 15;66(8):1555-61. doi: 10.1016/s0006-2952(03)00511-2.
3
The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex.肿瘤抑制因子 p53、p63 和 p73 是 microRNA 加工复合物的调节因子。
PLoS One. 2010 May 12;5(5):e10615. doi: 10.1371/journal.pone.0010615.
4
Therapeutic prospects for p73 and p63: rising from the shadow of p53.p73和p63的治疗前景:从p53的阴影中崛起。
Drug Resist Updat. 2008 Aug-Oct;11(4-5):152-63. doi: 10.1016/j.drup.2008.08.001. Epub 2008 Sep 17.
5
A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.肿瘤来源的p53突变形式的一个子集通过与p53核心结构域直接相互作用下调p63和p73。
Mol Cell Biol. 2001 Mar;21(5):1874-87. doi: 10.1128/MCB.21.5.1874-1887.2001.
6
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.基因组守护者(p53、TA-p73 和 TA-p63)是肿瘤抑制 miRNA 网络的调节剂。
Cancer Metastasis Rev. 2010 Dec;29(4):613-39. doi: 10.1007/s10555-010-9257-9.
7
MDM2 and MDMX can interact differently with ARF and members of the p53 family.MDM2和MDMX与ARF及p53家族成员的相互作用方式可能不同。
FEBS Lett. 2001 Feb 16;490(3):202-8. doi: 10.1016/s0014-5793(01)02124-x.
8
Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.SUMO-1对p73α的共价修饰。用p73进行双杂交筛选可鉴定出新的与SUMO-1相互作用的蛋白及一个SUMO-1相互作用基序。
J Biol Chem. 2000 Nov 17;275(46):36316-23. doi: 10.1074/jbc.M004293200.
9
p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress.p53/p63/p73 异构体:协调细胞分化与应激反应的异构体“管弦乐队”
Cell Death Differ. 2006 Jun;13(6):962-72. doi: 10.1038/sj.cdd.4401914.
10
The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.肿瘤抑制蛋白p53在体外激活转录方面的功能与p63和p73相似。
Cancer Biol Ther. 2005 Apr;4(4):414-8. doi: 10.4161/cbt.4.4.1619. Epub 2005 Apr 21.

引用本文的文献

1
Deletion of p63 exon 13 in mice reveals C-terminal isoform-specific functions in epithelial development.小鼠中p63外显子13的缺失揭示了上皮发育中C末端异构体特异性功能。
Proc Natl Acad Sci U S A. 2025 Jul 22;122(29):e2503866122. doi: 10.1073/pnas.2503866122. Epub 2025 Jul 17.
2
Targeting protein modification: a new direction for immunotherapy of pancreatic cancer.靶向蛋白质修饰:胰腺癌免疫治疗的新方向。
Int J Biol Sci. 2025 Jan 1;21(1):63-74. doi: 10.7150/ijbs.101861. eCollection 2025.
3
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors.
二甲双胍调控恶性肿瘤代谢重编程的研究进展。
Pharm Res. 2024 Nov;41(11):2143-2159. doi: 10.1007/s11095-024-03783-2. Epub 2024 Oct 25.
4
Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy.p53 调控的细胞命运:癌症治疗中的朋友还是可逆的敌人?
Cancer Commun (Lond). 2024 Mar;44(3):297-360. doi: 10.1002/cac2.12520. Epub 2024 Feb 4.
5
The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment.SUMOylation 相关基因的预后预测和免疫调节作用:前列腺癌治疗的潜在新靶点。
Int J Mol Sci. 2023 Sep 2;24(17):13603. doi: 10.3390/ijms241713603.
6
The Four Homeostasis Knights: In Balance upon Post-Translational Modifications.四大稳态骑士:在翻译后修饰中保持平衡。
Int J Mol Sci. 2022 Nov 21;23(22):14480. doi: 10.3390/ijms232214480.
7
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.癌症相关的 SUMO 调节因子失调:蛋白酶和连接酶。
Int J Mol Sci. 2022 Jul 20;23(14):8012. doi: 10.3390/ijms23148012.
8
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells.SUMO E3连接酶在癌细胞信号通路中的作用
Int J Mol Sci. 2022 Mar 26;23(7):3639. doi: 10.3390/ijms23073639.
9
Structural diversity of p63 and p73 isoforms.p63 和 p73 异构体的结构多样性。
Cell Death Differ. 2022 May;29(5):921-937. doi: 10.1038/s41418-022-00975-4. Epub 2022 Mar 21.
10
Regulation of p53 by E3s.E3 对 p53 的调控。
Cancers (Basel). 2021 Feb 11;13(4):745. doi: 10.3390/cancers13040745.